UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$494M |
| 2 |
Johnson & Johnson
JNJ
|
+$466M |
| 3 |
Procter & Gamble
PG
|
+$299M |
| 4 |
Amazon
AMZN
|
+$285M |
| 5 |
Advanced Micro Devices
AMD
|
+$256M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
VMW
VMware, Inc
VMW
|
+$510M |
| 2 |
ATVI
Activision Blizzard
ATVI
|
+$430M |
| 3 |
Microsoft
MSFT
|
+$315M |
| 4 |
Intel
INTC
|
+$227M |
| 5 |
SPLK
Splunk Inc
SPLK
|
+$169M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.22% |
| 2 | Healthcare | 12.65% |
| 3 | Consumer Discretionary | 11.43% |
| 4 | Financials | 11.23% |
| 5 | Communication Services | 7.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2451
Hagerty
HGTY
$1.22B
| $163K | ﹤0.01% |
20,855
| – | – |
|
2452
Microvast
MVST
$244M
| $160K | ﹤0.01% |
114,241
-131,102
| -53% | -$176K |
|
|
ME
2453
DELISTED
23andMe Holding Co
ME
| $154K | ﹤0.01% |
8,407
| – | – |
|
2454
Erasca
ERAS
$5.97B
| $152K | ﹤0.01% |
71,342
| – | – |
|
2455
Summit Therapeutics
SMMT
$9.88B
| $151K | ﹤0.01% |
57,800
| – | – |
|
2456
Marcus Corp
MCS
$762M
| $149K | ﹤0.01% |
10,225
| – | – |
|
2457
NerdWallet
NRDS
$632M
| $147K | ﹤0.01% |
10,000
| – | – |
|
2458
NuScale Power
SMR
$2.7B
| $145K | ﹤0.01% |
+44,200
| New | +$157K |
|
2459
Clover Health Investments
CLOV
$2.24B
| $135K | ﹤0.01% |
141,869
| – | – |
|
|
WOW
2460
DELISTED
WideOpenWest
WOW
| $133K | ﹤0.01% |
32,962
+12,734
| +63% | +$68.5K |
|
|
SHCR
2461
DELISTED
Sharecare, Inc. Class A Common Stock
SHCR
| $132K | ﹤0.01% |
122,400
| – | – |
|
|
OPI
2462
DELISTED
Office Properties Income Trust
OPI
| $132K | ﹤0.01% |
18,000
-43,940
| -71% | -$234K |
|
2463
Xponential Fitness
XPOF
$282M
| $129K | ﹤0.01% |
10,000
-2,200
| -18% | -$29.8K |
|
2464
Replimune Group
REPL
$429M
| $121K | ﹤0.01% |
+14,380
| New | +$167K |
|
2465
Tango Therapeutics
TNGX
$4.16B
| $121K | ﹤0.01% |
12,200
| – | – |
|
2466
Aclaris Therapeutics
ACRS
$709M
| $119K | ﹤0.01% |
113,601
| – | – |
|
2467
Phathom Pharmaceuticals
PHAT
$932M
| $118K | ﹤0.01% |
+12,893
| New | +$111K |
|
|
TERN
2468
DELISTED
Terns Pharmaceuticals
TERN
| $116K | ﹤0.01% |
+17,870
| New | +$94.5K |
|
2469
PLAYSTUDIOS Inc
MYPS
$76.1M
| $96.9K | ﹤0.01% |
35,773
| – | – |
|
2470
Holley
HLLY
$331M
| $92.6K | ﹤0.01% |
19,010
-10,701
| -36% | -$47.3K |
|
2471
Granite Ridge Resources
GRNT
$621M
| $92.1K | ﹤0.01% |
+15,300
| New | +$93.4K |
|
2472
Advantage Solutions
ADV
$559M
| $91.3K | ﹤0.01% |
1,009
| – | – |
|
2473
Vivid Seats
SEAT
$82M
| $89.7K | ﹤0.01% |
709
| – | – |
|
2474
ICL Group
ICL
$6.57B
| $86.6K | ﹤0.01% |
17,279
-2,010
| -10% | -$10.2K |
|
2475
NextNav
NN
$1.75B
| $84.2K | ﹤0.01% |
+18,931
| New | +$85.5K |
|
Similar funds
UBS AM's Q4 2023 Portfolio in Review
As of Q4 2023, UBS AM held 2,644 positions worth $254B, up 14% from $223B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
UBS AM's Q4 2023 filing shows 62 new, 1,338 increased, 675 reduced and 106 closed positions. Its largest new stake was Veralto: 1,187,566 shares worth $97.7M. The largest sale was VMware, Inc, an estimated $510M.
By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 30% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- UBS AM's largest Q4 2023 buy was Veralto: 1,187,566 shares worth $97.7M.
- UBS AM added most to Broadcom in Q4 2023, an estimated $494M increase.
- UBS AM's biggest Q4 2023 reduction was Microsoft, cutting an estimated $315M.
- UBS AM fully exited VMware, Inc in Q4 2023, selling an estimated $510M.
- UBS AM's ten largest holdings make up 26% of its $254B portfolio in Q4 2023.
- UBS AM opened 62 new positions and closed 106 in Q4 2023.
- UBS AM's portfolio value rose 14% quarter-over-quarter to $254B.
Based on UBS AM's 13F filing for Q4 2023, filed 14 Feb 2024.